Immunoglobulins Market 2025–2029: Strategic Opportunities and Growth Insights

Uncover key drivers, emerging technologies, and competitive movements shaping the immunoglobulins market from 2025–2034 with trusted insights from The Business Research Company

What Are The Market Size Estimates For The Immunoglobulins Market Now And By 2029?

The immunoglobulins market has shown significant expansion in recent years. Its value is anticipated to rise from $18.85 billion in 2024 to $20.32 billion in 2025, achieving a compound annual growth rate (CAGR) of 7.8%. This historical growth can be linked to a higher incidence of immunodeficiency disorders, an expanding older population, increased utilization of immunoglobulins in hospital settings, beneficial government reimbursement programs, and the rising occurrence of chronic and autoimmune diseases.

The immunoglobulins market is anticipated to experience substantial growth in the near future. By 2029, its value is forecast to reach $30.89 billion, exhibiting a compound annual growth rate (CAGR) of 11.0%. This anticipated growth is driven by factors such as greater investment in advanced technology development, heightened awareness of immunodeficiency therapies, an increasing preference among medical professionals for these treatments, the emergence of more markets, and the broadening of applications in areas like sports and fitness. Key trends during this period are expected to encompass the creation of wearable and smart compression devices, tailored compression therapy solutions, the incorporation of compression therapy into wound care management, a focus on patient comfort and adherence in compression therapy, and partnerships between manufacturers and healthcare providers to enhance patient results.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=5284&type=smp

Which Long-Term Drivers Are Expected To Sustain The Immunoglobulins Market?

The expanding geriatric population is a primary catalyst for the growth of the immunoglobulins market. Elderly individuals are highly susceptible to infectious diseases and auto-immune conditions. An immunoglobulin test measures the body’s capacity to produce antibodies that provide defense against bacteria, viruses, and allergies. For example, in October 2022, a report from the World Health Organization (WHO), a Switzerland-based agency dedicated to international public health, indicated that by 2030, one in six people worldwide is projected to be 60 or older. This trend continues, with 2.1 billion people globally expected to be 60 years old or older by 2050. Therefore, the rising geriatric population is set to boost the demand for the immunoglobulins market over the forecast period.

How Is The Immunoglobulins Market Classified By Different Segments?

The immunoglobulins market covered in this report is segmented –

1) By Product: IGG, IGA, IGM, IGE, IGD.

2) By Mode Of Delivery: Intravenous Mode Of Delivery, Subcutaneous Mode Of Delivery

3) By Application: Hypogammaglobulinemia, Chronic Inflammatory demyelinating polyneuropathy (CIDP), Immunodeficiency Disease, Myasthenia Gravis, Idiopathic thrombocytopenic purpura (ITP), Other Applications

Subsegments:

1) By IGG (Immunoglobulin G): IVIG (Intravenous Immunoglobulin), SCIG (Subcutaneous Immunoglobulin)

2) By IGA (Immunoglobulin A): Monoclonal IGA, Polyvalent IGA

3) By IGM (Immunoglobulin M): Monoclonal IGM, Polyvalent IGM

4) By IGE (Immunoglobulin E): Allergen-Specific IGE, Monoclonal IGE

5) By IGD (Immunoglobulin D): Research-Use IGD, Monoclonal IGD

What Current And Upcoming Trends Are Shaping The Immunoglobulins Market?

Leading companies in the immunoglobulins market are developing innovative products like intravenous immunoglobulins to attract larger customer bases, boost sales, and enhance revenue. For instance, in September 2024, GC Biopharma, a South Korean-based biotechnology company, launched ALYGLO™ (Immune Globulin Intravenous, Human-stwk) 10% Liquid in the U.S. market, intended for the treatment of primary humoral immunodeficiency (PI) in adults aged 17 years and older. This product is now accessible to patients via specialty pharmacies. The introduction is noteworthy because the U.S. represents the largest global immunoglobulin market, with an approximate valuation of $11.6 billion. GC Biopharma targets $50 million in sales for ALYGLO in its initial year, with projections to increase this amount to $300 million by 2028. This extensive growth strategy involves collaborations with major U.S. pharmacy benefit managers and specialty pharmacies, which are essential for the efficient distribution of immunoglobulin products.

Who Are The Primary Market Leaders In The Immunoglobulins Market?

Major companies operating in the immunoglobulins market include Baxter International Inc., CSL Behring LLC, Grifols S. A., Octapharma AG, China Biologic Products Holdings Inc., Kedrion SpA, LFB SA, Biotest AG, Sanquin Blood Supply Foundation, ADMA Biologics Inc., Option Care Health Inc., Shanghai RAAS Blood Products Co. Ltd., Antibody Solutions, Bio Products Laboratory Ltd., Immunovant Inc., Kamada Ltd., Emergent BioSolutions Inc., Fresenius Kabi AG, GlaxoSmithKline plc, Pfizer Inc., Roche Holding AG, Samsung Bioepis Co. Ltd., Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Zydus Cadila Healthcare Limited

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/immunoglobulins-global-market-report

Which Regional Markets Are Emerging As Key Centers For The Immunoglobulins Market?

North America was the largest region in the immunoglobulins market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the immunoglobulins market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=5284&type=smp

Browse Through More Reports Similar to the Global Immunoglobulins Market 2025, By The Business Research Company

Orphan Drug Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/orphan-drug-global-market-report

Drug Delivery Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/drug-delivery-devices-global-market-report

Autoimmune Disease Diagnosis Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/autoimmune-disease-diagnosis-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795